CBD for Dog Lymphoma: Comfort Care During Cancer Treatment
Quick Answer: While CBD cannot treat lymphoma, many pet owners report that it may help support comfort during cancer treatment...
Read moreAffiliate Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
Liver disease in dogs is increasingly common, whether from infection, toxins, age, or genetic predisposition. As the liver filters toxins and supports digestion, its health is vital. While CBD isn’t a cure, some owners explore it as supportive care alongside veterinary treatment.
Liver disease involves inflammation. CBD’s anti-inflammatory properties may ease stress on damaged liver tissue and support healing processes.
The liver metabolizes CBD, so dosing must be adjusted for dogs with liver disease. Always work with your veterinarian on appropriate amounts.
Some dogs with severe liver disease develop hepatic encephalopathy (brain symptoms). Early evidence suggests CBD may help reduce some neurological symptoms, though research is ongoing.
Begin with 1-2mg CBD per pound of body weight, significantly lower than typical doses. Monitor liver enzyme levels closely.
Frequent blood work is needed to monitor liver function. Adjust CBD based on bloodwork results and your vet’s recommendations.
Liver disease requires specialized veterinary care, possibly including medications like ursodeoxycholic acid or silymarin. CBD should only be used with explicit veterinary approval and alongside conventional treatment.
For a dog with liver disease, the purity of any supplement is critical. Choose products with:
Liver function tests should improve or stabilize with proper treatment. Track appetite, energy, and visible symptoms. If your dog worsens, stop CBD and consult your vet immediately.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Pets’ endocannabinoid systems respond to CBD similarly to humans, though with different metabolism and sensitivity thresholds. Research on pet CBD grows yearly, with veterinary schools now researching cannabinoid therapy. While long-term safety studies are ongoing, short-term use shows excellent safety profiles with minimal side effects in most pets.
Start with conservative doses and monitor your pet closely. For anxiety or mild pain: 1-2mg per 10 lbs daily. For moderate issues: 2-5mg per 10 lbs daily. For severe conditions: up to 5mg per 10 lbs with veterinary guidance. Divide daily dose into morning and evening for consistent symptom control. Track dose and response in a log to optimize over time.
Pet-formulated CBD oils are most popular—easy to dose, quick absorption, and adjustable. CBD treats offer convenience for picky eaters. Topical options work best for localized pain or skin issues. Avoid human products with added ingredients, sweeteners, or flavoring that may upset pet digestion. Always verify third-party testing and contact manufacturers with questions about pet formulations.
CBD works synergistically with traditional veterinary care. For pain: combine with appropriate pain medications as approved by your vet. For anxiety: pair with training, desensitization, and calming environment changes. For skin issues: use with appropriate medicated shampoos and allergen avoidance. CBD enhances the effectiveness of comprehensive care plans.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more